Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
After finishing at $0.43 in the prior trading day, Verrica Pharmaceuticals Inc (NASDAQ: VRCA) closed at $0.44, up 2.12%. In other words, the price has increased by $2.12 from its previous closing price. On the day, 0.53 million shares were traded. VRCA stock price reached its highest trading level at $0.4481 during the session, while it also had its lowest trading level at $0.3861.
Ratios:
Our goal is to gain a better understanding of VRCA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.68 and its Current Ratio is at 1.76.
Needham Upgraded its Hold to Buy on July 25, 2023, while the target price for the stock was maintained at $10.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 17 ’25 when Hayes Christopher G. sold 4,315 shares for $0.65 per share. The transaction valued at 2,805 led to the insider holds 176,458 shares of the business.
Hayes Christopher G. sold 26,183 shares of VRCA for $69,647 on Aug 26 ’24. The CHIEF LEGAL OFFICER now owns 115,303 shares after completing the transaction at $2.66 per share. On Aug 27 ’24, another insider, Hayes Christopher G., who serves as the CHIEF LEGAL OFFICER of the company, sold 9,530 shares for $2.46 each. As a result, the insider received 23,444 and left with 105,773 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VRCA now has a Market Capitalization of 40585116 and an Enterprise Value of 40195112. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.36. Its current Enterprise Value per Revenue stands at 5.313 whereas that against EBITDA is -0.627.
Stock Price History:
The Beta on a monthly basis for VRCA is 1.69, which has changed by -0.9249576 over the last 52 weeks, in comparison to a change of 0.077997446 over the same period for the S&P500. Over the past 52 weeks, VRCA has reached a high of $11.41, while it has fallen to a 52-week low of $0.42. The 50-Day Moving Average of the stock is -30.96%, while the 200-Day Moving Average is calculated to be -81.92%.
Shares Statistics:
The stock has traded on average 404.27K shares per day over the past 3-months and 676340 shares per day over the last 10 days, according to various share statistics. A total of 91.78M shares are outstanding, with a floating share count of 49.69M. Insiders hold about 45.85% of the company’s shares, while institutions hold 32.67% stake in the company. Shares short for VRCA as of 1741910400 were 2221927 with a Short Ratio of 5.50, compared to 1739491200 on 1991664. Therefore, it implies a Short% of Shares Outstanding of 2221927 and a Short% of Float of 3.26.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
